Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Mult Scler Relat Disord ; 53: 103031, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34077830

RESUMO

BACKGROUND: Despite significant interest in diet by the MS community, research on this topic is limited; there are no published studies evaluating associations between diet and neuroimaging in MS. METHODS: We utilized baseline data from the RADIEMS cohort of early MS (diagnosed <5.0 years, n=180). Participants underwent brain MRIs to derive normalized total gray and thalamic volumes, T2 lesion volume, and white matter microstructural integrity of normal appearing white matter (NAWM). Participants completed food frequency questionnaires (FFQ) from which we calculated adherence scores to pre-specified dietary patterns including the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet. We evaluated intake of the following pre-specified dietary components: fruits, vegetables, legumes, nuts, whole grains, dairy, fried foods, processed meats, and fat intake. We used multivariable-adjusted linear regression to evaluate MRI metrics versus dietary measures. RESULTS: MIND diet score was associated with thalamic volume; individuals in the highest quartile of MIND diet scores had greater thalamic volumes versus those in the lowest quartile (Q4 vs. Q1: 1.03mL; 95%CI: 0.26mL, 1.79mL; p<0.01). For individual food/nutrients, higher intakes of full-fat dairy were associated with lower T2 lesion volumes (Q4 vs. Q1: -0.93mL; 95%CI: -1.51mL, -0.35ml; p<0.01). Higher intakes of marine omega-3 fatty acids were associated with greater NAWM microstructural integrity (Q4 vs. Q1: 0.40; 95%CI: 0.03, 0.76; p=0.04). Other foods/nutrients were not associated with MRI outcomes. CONCLUSIONS: In this first study focused on neuroimaging and diet in MS, we note significant associations in a cross-sectional early MS cohort. Longitudinal follow-up of imaging/clinical outcomes will provide additional insights.


Assuntos
Dieta Mediterrânea , Esclerose Múltipla , Benchmarking , Estudos Transversais , Humanos , Imageamento por Ressonância Magnética , Esclerose Múltipla/diagnóstico por imagem
2.
J Clin Invest ; 63(5): 1077-84, 1979 May.
Artigo em Inglês | MEDLINE | ID: mdl-447829

RESUMO

Nonsuppressible insulin-like activity extracted and purified from human serum (NSILA-S) mimics all insulin-like effects in vitro and, after injection, in vivo in the presence of excess insulin antibodies. However, there is no evidence that it exerts acute insulin-like effects in its native form in the circulation, where it is almost completely bound to a specific large molecular weight carrier protein. In this paper we show that partially purified NSILA-S-carrier protein, devoid of endogenous insulin-like activity, inhibits the stimulatory effect of NSILA-S, but not of insulin, on 3-0-methylglucose transport and on lipogenesis from [U-(14)C]glucose in isolated rat fat cells. Concomitantly, it prevents binding of (125)I-labeled NSILA-S to the insulin receptor and to the NSILA-S-binding site. The following explanation is, therefore, offered for the absence of acute insulin-like effects of native NSILA-S in vivo: In native serum NSILA-S occurs almost exclusively as NSILA-S-carrier complex. According to recent findings the passage of this complex through blood capillaries is restricted. The present results indicate that, in addition, it is metabolically inactive, or, at least, possesses reduced metabolic activity. The well-known phenomenon that whole serum, nevertheless, exerts pronounced nonsuppressible insulin-like effects on adipose tissue in vitro seems, therefore, to be mainly caused by the presence of a large molecular weight insulin-like protein not identical to the NSILA-S-carrier complex.


Assuntos
Tecido Adiposo/metabolismo , Proteínas de Transporte/metabolismo , Atividade Insulin-Like não Suprimível/farmacologia , Animais , Cromatografia em Gel , Técnicas In Vitro , Metabolismo dos Lipídeos , Masculino , Metilglucosídeos/metabolismo , Atividade Insulin-Like não Suprimível/antagonistas & inibidores , Ligação Proteica , Ratos
3.
J Cardiovasc Pharmacol Ther ; 22(3): 239-249, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28399647

RESUMO

Cocaine abuse remains a significant worldwide health problem. Patients with cardiovascular toxicity from cocaine abuse frequently present to the emergency department for treatment. These patients may be tachycardic, hypertensive, agitated, and have chest pain. Several pharmacological options exist for treatment of cocaine-induced cardiovascular toxicity. For the past 3 decades, the phenomenon of unopposed α-stimulation after ß-blocker use in cocaine-positive patients has been cited as an absolute contraindication, despite limited and inconsistent clinical evidence. In this review, the authors of the original studies, case reports, and systematic review in which unopposed α-stimulation was believed to be a factor investigate the pathophysiology, pharmacology, and published evidence behind the unopposed α-stimulation phenomenon. We also investigate other potential explanations for unopposed α-stimulation, including the unique and deleterious pharmacologic properties of cocaine in the absence of ß-blockers. The safety and efficacy of the mixed ß-/α-blockers labetalol and carvedilol are also discussed in relation to unopposed α-stimulation.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Doenças Cardiovasculares/tratamento farmacológico , Sistema Cardiovascular/efeitos dos fármacos , Estimulantes do Sistema Nervoso Central/efeitos adversos , Transtornos Relacionados ao Uso de Cocaína/complicações , Cocaína/efeitos adversos , Hemodinâmica/efeitos dos fármacos , Receptores Adrenérgicos alfa/efeitos dos fármacos , Sistema Nervoso Simpático/efeitos dos fármacos , Antagonistas Adrenérgicos beta/efeitos adversos , Animais , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/metabolismo , Doenças Cardiovasculares/fisiopatologia , Sistema Cardiovascular/inervação , Sistema Cardiovascular/metabolismo , Transtornos Relacionados ao Uso de Cocaína/metabolismo , Transtornos Relacionados ao Uso de Cocaína/fisiopatologia , Humanos , Receptores Adrenérgicos alfa/metabolismo , Sistema Nervoso Simpático/metabolismo , Sistema Nervoso Simpático/fisiopatologia , Resultado do Tratamento
4.
J Emerg Med ; 12(6): 803-9, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7884200

RESUMO

D5W is the maintenance fluid often used in prehospital care when transporting patients with cardiac or central nervous system processes. However, there is evidence that dextrose solutions are potentially harmful, and that suggests isotonic crystalloid solutions are the preferred maintenance fluid in treating emergent patients regardless of their underlying disease. Dextrose solutions may exacerbate cellular ischemic damage and they cannot be used to resuscitate hypotensive patients. Crystalloids do not cause fluid overload when used at maintenance rates and are effective resuscitative agents in managing hypotension. The use of a single crystalloid solution in the prehospital environment would simplify equipment stocking and management protocols, minimize cost, and would not have an adverse impact on patient care.


Assuntos
Glucose/uso terapêutico , Soluções Isotônicas/uso terapêutico , Ressuscitação/métodos , Animais , Serviços Médicos de Emergência , Glucose/efeitos adversos , Insuficiência Cardíaca/etiologia , Humanos , Soluções Isotônicas/efeitos adversos , Edema Pulmonar/etiologia
8.
Am J Emerg Med ; 9(2): 161-3, 1991 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1671639

RESUMO

The authors report their experience using esmolol, an ultra-short acting beta-adrenergic antagonist, for the treatment of seven patients with cocaine-associated cardiovascular complications. No consistent hemodynamic benefit was found with the use of this drug. Although there was a decline in mean heart rate of 23% (range 0% to 35%), they were unable to show a consistent antihypertensive response. Adverse effects occurred in three patients. This included one patient with a marked exacerbation of hypertension and one who became hypotensive. Another patient developed emesis and lethargy during esmolol therapy and required endotracheal intubation. They do not recommend the routine use of esmolol for cocaine cardiotoxicity.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Doenças Cardiovasculares/tratamento farmacológico , Cocaína , Serviço Hospitalar de Emergência , Propanolaminas/uso terapêutico , Transtornos Relacionados ao Uso de Substâncias/complicações , Antagonistas Adrenérgicos beta/administração & dosagem , Antagonistas Adrenérgicos beta/farmacologia , Adulto , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/fisiopatologia , Feminino , Georgia , Hemodinâmica/efeitos dos fármacos , Hospitais de Ensino , Humanos , Infusões Intravenosas , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Propanolaminas/administração & dosagem , Propanolaminas/farmacologia
9.
Eur J Biochem ; 113(3): 605-9, 1981 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7011799

RESUMO

Trypsin-treatment of isolated rat adipocytes abolishes the metabolic effects not only of insulin, but also of the insulin-like growth factors: in trypsin-treated cells, concentrations of these hormones that are otherwise maximally effective no longer stimulate 3-O-methylglucose transport and lipogenesis or inhibit epinephrine induced lipolysis. Concomitantly, the trypsin-treated adipocytes no longer display specific insulin binding. In contrast, the characteristics of the binding of the insulin-like growth factors are not grossly affected by prior trypsinization of the adipocytes. These findings add further support to the concept that the insulin-like growth factors act on glucose metabolism and antilipolysis via the insulin receptor of the adipocyte.


Assuntos
Tecido Adiposo/metabolismo , Insulina/metabolismo , Peptídeos/metabolismo , Receptor de Insulina/efeitos dos fármacos , Somatomedinas/metabolismo , Tripsina/farmacologia , 3-O-Metilglucose , Tecido Adiposo/efeitos dos fármacos , Animais , Técnicas In Vitro , Insulina/farmacologia , Lipólise/efeitos dos fármacos , Metilglucosídeos/metabolismo , Peptídeos/farmacologia , Ratos , Receptor de Insulina/metabolismo , Somatomedinas/farmacologia
10.
Sci. med ; 15(1): 34-41, 2005.
Artigo em Português | LILACS | ID: lil-445249

RESUMO

O presente estudo tem como objetivo identificar as repercussões de uma gestação da vida da adolescente, dado os crescentes índices de gravidez na adolescência. Caracteriza-se como um estudo qualitativo de abordagem descritiva. Para a coleta dos dados foram utilizadas entrevistas abertas a dez mulheres adultas que que engravidaram no período da adolescência, domicialiadas em três municípios da Região Noroeste do Estado do Rio Grande do Sul. Os dados foram analizados seguindo proposta metodológica de Minayo citada por Gomes (1999). Emergiram três categorias de análise de estudo, das quais apresenta-se duas artigo: a "experiência da gravidez no período da adolescência, com as respectivas repercussões em suas vidas", os "sentimentos experimentados por conta da vivência da gestação na adolescência", os quais têm estreita relação com as repercuções. Considera-se frente aos resultados estudo que os profissionais da área de saúde precisam envidar esforços no sentido que se delenei uma transformção cultural , na qual se passe a perceber o adolescente como sujeito que é, e não está por vir ser. Pois, enquanto o adolescente for consideradp, cultural e socialmente, como um invíduo que "apenas" procura por uma identidade e nada é, ele poderá lançar mão de subterfúgios, tais como gravidez, para alcançar visibilidade, o que ao invés de auxiliarem-no no alcanceede tal intento, contribuirão para um desfecho de oportunidades cada vez escassas tornando-o um adulto invisível e infeliz.


Assuntos
Humanos , Feminino , Gravidez , Adolescente , Gravidez na Adolescência , Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA